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Ergot alkaloids are among the most relevant natural products in the history of toxins and 
pharmaceuticals. Until the late 20th century, human and livestock exposure to ergot alkaloids was 
primarily through ingestion of “ergots,” which are spur-shaped or seed-like resting structures (sclerotia) 
of ergot fungi, the Claviceps species. Because ergots have similar density to grains, traditional threshing 
techniques generally failed to remove them, and outbreaks of ergot typically led to mass poisonings.  
The self-pollinating habit of wheat greatly limits ergot infestation, but other grain crops such as rye, 
barley and pearl millet more frequently host Claviceps ergots. Human poisoning came to be known in 
medieval Europe as “St. Anthony’s fire,” which was described as entailing a number of symptoms ranging 
from convulsions and hallucinations to dry gangrene and limb loss, and could be fatal. The causative 
agents of most ergot poisonings are the ergot alkaloid class of fungal metabolites, though some ergot 
fungi produce distantly related indole-diterpene alkaloids that are tremorgenic. Ergot alkaloids also have  
had medical applications for centuries, first in obstetrics to promote labor and reduce uterine  
hemorrhaging [1], and most recently in treatment of migraines and various neurological and 
endocrinological disorders including parkinsonism [2–4]. Their realized and hypothesized medicinal 
uses have encouraged intensive research since the 1950s culminating on the one hand in development 
of drugs both legal (e.g., bromocriptine) and illegal (e.g., lysergic acid diethylamide = LSD), and on the 
other hand in extensive knowledge of the enzymes, genetics, and diversity of ergot alkaloid biosynthetic 
pathways as described in this issue. Likewise, their presence in some endophyte-symbiotic grasses, and 
their negative effects on livestock production, have spurred research into the agroecology of these toxins. 
All of these subjects have advanced particularly far in recent years, so this is an opportune time to present 
this Special Issue on ergot alkaloids. 
Nothing about ergot alkaloids is simple, considering their many neurotropic and pharmacological 
activities, the variety of ecosystems, plant-fungus infections and symbioses in which they are found, 
their effects on plant ecology and implications in livestock agriculture, their exceptional chemical 
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diversity, and even the history and social implications of ergot alkaloid poisoning and recreational use 
of LSD. This Special Issue focuses on the ecological and agricultural aspects of the ergot alkaloids.  
An overview of the biosynthetic pathway is presented by Gerhards et al. [5], and Robinson and  
Panaccione [6] explore the biochemical basis for diversification of ergot alkaloids in nature as well as 
implications for laboratory manipulations of ergot alkaloid-producing fungi that result in profiles altered 
in sometimes unexpected ways. The genetics and genomic structures that underlie evolutionary 
diversification of these alkaloids are reviewed by Young et al. [7]. To aid the reader in cross-referencing 
these contributions, I present here a listing of the ergot alkaloid synthesis (eas) genes and the enzymes 
that they encode, as well as a key to the gene designations used for different organisms and on gene 
maps in this Special Issue (Table 1). 
Considering that the many forms of ergot alkaloids have different pharmacological properties, 
providing for highly successful development of several important drugs, the basis for ergot-alkaloid 
diversity is of considerable interest. In recent years, it has become evident that several evolutionary 
processes have acted to diversify the array of ergot alkaloids produced by fungi. Differences in enzyme 
activities are evident at the levels of substrate specificity (LpsA), product specification (EasA, CloA) or 
both (EasG and possibly CloA) [6]. The “old yellow enzyme,” EasA, presents an outstanding example. 
This enzyme catalyzes reduction of the C8=C9 double-bond in chanoclavine I, but EasA isoforms differ 
in whether they subsequently catalyze reoxidation of C8–C9 after rotation. This difference distinguishes 
most Clavicipitaceae from Trichocomaceae, but in Clavicipitaceae it is also the key difference dividing 
the branch of classical ergot alkaloids from dihydroergot alkaloids, the latter often being preferred for 
pharmaceuticals due to their relatively few side effects. 
Genomic alternations provide other means to alter and diversify ergot alkaloid profiles [7]. In most 
species examined the evidence indicates that eas genes occupy a single cluster, designated the EAS 
cluster. A set of seven orthologs is shared between Trichocomaceae and Clavicipitaceae, dmaW, easF, 
easC, easE, easD, easA and easD, listed in order of function of the enzymes that they specify for the 
biosynthesis of festuclavine (in Trichocomaceae) or agroclavine (in most Clavicipitaceae). Fungi in each 
family differ in subsequent modifications attributable mostly to enzyme classes common in specialized 
metabolite gene clusters, such as cytochromes P450 (cloA, easK, easM) and nonribosomal peptide 
synthetases (lpsA, lpsB, lpsC), as well as a prenyltransferase (easL) and acetyltransferase (easN). Thus, 
these clusters have been assembled by acquiring and neofunctionalizing genes. Relationships of the lps 
genes suggest that the process involved gene duplications, and, highlighting that possibility, the 
Claviceps purpurea 20.1 EAS cluster has duplicate lpsA genes that specify different ergopeptines.  
In fact, and quite mysteriously, C. purpurea lineages have evolved an exaltation of LpsA variants to give 
most of the 20 different ergopeptines found to date. 
Evolutionary processes at the genome level sometimes lead to greater simplicity [7]. For example, 
some Epichloë species, as well as Claviceps fusiformis, have lost genes for late-pathway steps, and 
instead make the relatively simple clavines. Even the emergence of new late-pathway steps specified by 
lpsC, easO and easP leads to products such as ergonovine, LAH and ergine (lysergyl amide), which are 
much simpler in structure than ergopeptines. However, since these pathways seem inefficient at channeling 
to the final product (i.e., “leaky”), more steps generally means a greater variety of ergot alkaloids, 
allowing the fungus to deal from an even deeper set of metabolites to defend itself and its host [6]. 
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Table 1. Gene names and enzyme functions in ergot alkaloid biosynthesis. 
General 
gene name 
Abbreviation Enzyme 
Species and strain 
Neosartorya 
fumigatus 
Af293 
Periglandula 
ipomoeae 
IasaF13 
Claviceps  
purpurea  
20.1 
Epichloë 
festucae 
Fl1 
easA A 
chanoclavine-I aldehyde oxidoreductase; old yellow enzyme;  
reduction or isomerization of C8=C9 bond 
fgaOx3  
(easA-red) 
easA-iso easA-iso easA-iso 
cloA B 
agroclavine, festuclavine, elymoclavine or lysergol monooxygenase,  
oxidation of C17 to alcohol or carboxyl 
– cloA cloA cloA 
easC C catalase involved in chanoclavine-I synthesis fgaCat easC easC easC 
easD D chanoclavine-1 dehydrogenase fgaDH easD easD easD 
easE E chanoclavine-I synthase fgaOx1 easE ccsA easE 
easF F dimethylallyltryptophan N-methyltransferase fgaMT easF easF easF 
easG G agroclavine, festuclavine or pyroclavine synthase; reduction of C7=N iminium ion fgaFS easG easG easG 
easH H ergopeptide lactam hydroxylase – easH easH easH 
easK K cytochrome P450; possible festuclavine 9-monooxygenase fgaP450-1 – – – 
easL L fumigaclavine reverse prenyltransferase fgaPT1 – – – 
easM M cytochrome P450, possible festuclavine 9-monooxygenase fgaP450-2 – – – 
easN N fumigaclavine acetylase fgaAT – – – 
easO O FAD-containing monooxygenase; putative ergonovine dehydrogenase – easO – – 
easP P 
alpha/beta hydrolase fold protein; putative lysergic acid α-hydroxyethylamide  
(LAH) synthase 
– easP – – 
dmaW W dimethylallyltryptophan synthase fgaPT2 dmaW Cpd1 dmaW 
lpsA lpsA lysergyl peptide synthetase subunit 1; specifies amino acids 1, 2 and 3 – lpsA-ERB 
see lpsA1 and  
lpsA2 below 
lpsA-ERV 
lpsA1 lpsA1 lysergyl peptide synthetase subunit 1; specifies Ala, Phe and Pro – – Cpps1 = lpsA-ERA – 
lpsA2 lpsA2 lysergyl peptide synthetase subunit 1; specifies Val, Leu and Pro – – Cpps4 = lpsA-ERK – 
lpsB lpsB lysergyl peptide synthetase subunit 2; specifies lysergic acid – lpsB Cpps2 lpsB 
lpsC lpsC lysergyl peptide synthetase and reductase subunit; specifies L-alanine – lpsC Cpps3 – 
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Additionally in this issue, Crews [8] provides details on chemical detection and analysis of ergot 
alkaloids by liquid chromatography and tandem mass spectrometry (LC-MS/MS), or by liquid 
chromatography with fluorescence detection (LC-FLD). Such sensitive and definitive approaches as 
currently available or under development are crucial to efforts in food and feed safety, studying ergot 
alkaloids in plant materials, and investigating activities and metabolism of ergot alkaloids in animals.  
Guerre [9] discusses the variety of ergot alkaloids produced by Epichloë species, which are notable 
for their ecological niches as systemic symbionts of cool-season grasses. Various toxic syndromes are 
associated with ergot alkaloids, commonly present in the grass, tall fescue (Lolium arundinaceum),  
with common strains of its endophyte, Epichloë coenophiala, as well as in perennial ryegrass (Lolium 
perenne) with common strains of Epichloë festucae var. lolii. Symptoms vary based on the chemical 
forms of the alkaloids, the additional presence of other alkaloids, such as indole-diterpenes, and 
environmental variables. In fact the lolitrems, a subclass of indole-diterpenes, are implicated in the most 
acute symptoms suffered by sheep and other livestock when grazed on perennial ryegrass. Whether there 
is any interaction between ergot alkaloids and indole-diterpenes has not been adequately addressed to date.  
A detailed overview of the toxicities in mammalian livestock is presented by Klotz [10]. Generally 
the activities are attributable to antagonism or agonism of neurotransmitters, including dopamine, 
serotonin and norepinephrine. The adrenergic blockage by ergopeptines (e.g., ergovaline or ergotamine) 
leads to potent and long-term vasoconstriction, and can result in reduced blood flow resulting in intense 
burning pain (St. Anthony’s fire), edema, cyanosis, dry gangrene and even loss of hooves in cattle or 
limbs in humans. Reduced prolactin due to ergot alkaloid activity on dopamine receptors in the pituitary 
is also common in livestock. Reduced serum prolactin is associated with various reproductive problems 
in cattle, and especially in horses, including agalactia and poor conception, and late-term losses of foals 
and sometimes mares due to dystocia and thickened placentas. 
Miedaner [11] presents an excellent overview of ergot in Europe, including convulsive and 
gangrenous ergotism. He follows with descriptions of the life cycles of ergot fungi including Claviceps 
africanus, Claviceps sorghi and C. purpurea. Grass species with cleistogamous florets—i.e., florets that 
self-pollinate before opening—tend to avoid ergot-fungus infections, and this largely explains why ergots 
are much more common on ears of rye and pearl millet than on wheat, barley and sorghum. Given the 
importance of cleistogamy as a protection from Claviceps spp., ergot is a problem during production  
of hybrids produced by employing male sterility or other means. Therefore, additional mechanisms of 
avoidance or resistance are of considerable interest. Miedaner [11] reviews the current knowledge of 
such mechanisms, and makes clear that more study is needed. Breeding and management practices are 
needed for hybrids that have full pollen production and fertility to reduce incidences of ergot. 
This Special Issue also features several research papers, for which follow brief synopses.  
Steiner et al. [12] provide new insight into the interactions of morning glories with the epibiotic 
endophytes, the Periglandula species, which are responsible for occurrence of toxic levels of ergot 
alkaloids and, sometimes, indole-diterpenes in foliage and seeds of these plants. Peltate glandular 
trichomes on adaxial leaf surfaces secrete a variety of lipids, including several sesquiterpenes as well as 
palmitic acid. Given the physical associations of Periglandula mycelia with these glands, it seems likely 
that these lipids are the primary carbon and energy source for the fungus. Their ultrastructural studies 
reveal appressorium-like structures that are produced by Periglandula and associated with degradation 
of the cuticular layer of the gland surface. Furthermore, a UV-fluorescence study supported the previous 
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observations by this group [13] that alkaloids were lost from fungal mycelia on leaf panels, but 
accumulated in the leaves. These results support a model for function of the glands in two-way transport, 
thus as a crucial interface enabling this symbiosis. 
Dänicke [14] investigated ergot toxicity in Pekin ducks, and titrated the lowest observed adverse 
effect level (LOAEL) for total ergot alkaloids (TEA) at 0.6 mg TA/kg diet. Given that the current 
European Union threshold is 1 g ergot/kg unground cereal grains, and that the mean TEA for ergots was 
0.7 mg/g, this pronounced sensitivity implied that the current regulations are insufficient to avoid toxicity 
to ducks. Within one week the choice-fed ducks learned to avoid ergot-containing diet, and the ducks 
dramatically decreased weight gain, though the ratio of feed intake to gain increased slightly but 
significantly in ducks fed increasing proportions of ergot in diets.  
The most famous—or infamous—of the Clavicipitaceae is Claviceps purpurea, which is the primary 
source of pharmaceutical ergot alkaloid, the cause of mass outbreaks of St. Anthony’s fire due to 
infection of rye and barley ears, and the species implicated rightly or wrongly in the Salem witch trials 
and others. The vast majority of ergopeptines are from strains identified as C. purpurea [7]. However, 
the circumscription of this species was recently refined in studies by Pažoutová et al. [15], in which 
Claviceps humidiphila, Claviceps arundinis and Claviceps spartinae were described. Negård et al. [16] 
have surveyed ergots in Norway and provide new insights into the taxonomic, chemotypic and ecotypic 
relationships of the C. purpurea complex. Their results support the recently proposed C. purpurea sensu 
stricto (s.s.), C. humidiphila and C. arundinis. Whereas ergopeptines were typical of C. purpurea s.s., 
C. humidiphila produced high levels of the ergopeptide lactams, ergocristam and ergosedmam. 
(Ergopeptide lactams are immediate precursors of ergopeptines, to which they can be converted by the 
action of the EasH hydroxylase [17].) Identification of indole-diterpenes from C. arundinis and  
C. humidiphila [16] is of interest in light of the defective indole-diterpene gene cluster in the sequenced 
genome of C. purpurea 20.1, and in keeping with the co-occurrence of indole-diterpenes and ergot 
alkaloids in other Clavicipitaceae [18]. 
It is my hope that this Special Issue will be a resource for many years to those scientists and lay 
persons interested in the agricultural and ecological relevance of ergot alkaloids, and their fascinatingly 
intricate biosynthetic pathways with enzymatic and evolutionary twists that have produced an 
extraordinarily diverse array of both problematic and useful compounds in this class. 
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